𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Activation and up-regulation of translation initiation factor 4B contribute to arsenic-induced transformation

✍ Scribed by Yong Zhang; Qing Wang; Xiaoling Guo; Robert Miller; Yinglu Guo; Hsin-Sheng Yang


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
690 KB
Volume
50
Category
Article
ISSN
0899-1987

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Arsenic is a known human carcinogen. However, the mechanism of how arsenic induces cell transformation remains unclear. In this study, we demonstrated that long‐term exposure to sodium arsenite at low‐dose (2 µM) increases cell proliferation and neoplastic transformation in a mouse epidermal cell model, JB6 promotion‐susceptible cells. The phosphorylation of AKT and its downstream targets, 70‐kDa ribosomal protein S6 kinase (p70S6K) and translation initiation factor 4B (eIF4B), are increased in the arsenite treated cells, indicating that long‐term arsenite treatment activates AKT–p70S6K signaling pathway. In addition, long‐term exposure to arsenite up‐regulates eIF4B expression and increases the rate of translation. Knockdown of eIF4B expression resulted in inhibition of arsenic‐induced cell proliferation, transformation, and translation. Moreover, the expression of c‐Myc which is up‐regulated by long‐term arsenite treatment is inhibited by eIF4B knockdown. Taken together, these results indicate that activation and up‐regulation of eIF4B contributes to arsenic‐induced transformation in JB6 cells. Mol. Carcinog. © 2011 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Contributions of mitogen-activated prote
✍ Keiji Shimada; Mitsutoshi Nakamura; Eiwa Ishida; Munehiro Kishi; Shin Yonehara; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB

## Abstract The synthetic retinoid __N__‐(4‐hydroxyphenyl)retinamide (4‐HPR) has been shown to induce apoptosis in various types of tumors, including prostate cancer. We sought to examine the key mechanisms affecting the resistance to 4‐HPR–induced apoptosis in three human prostate cancer cell line